Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,022
Closed -$888K 381
2025
Q2
$888K Buy
+9,022
New +$854K 0.47% 52
2025
Q1
Sell
-9,476
Closed -$860K 220
2024
Q4
$860K Buy
9,476
+1,976
+26% +$181K 0.58% 44
2024
Q3
$724K Sell
7,500
-17,500
-70% -$1.71M 0.36% 77
2024
Q2
$2.29M Buy
25,000
+7,423
+42% +$689K 1.25% 12
2024
Q1
$1.62M Sell
17,577
-362
-2% -$33.9K 0.9% 23
2023
Q4
$1.71M Sell
17,939
-7,761
-30% -$725K 1.04% 16
2023
Q3
$2.4M Buy
25,700
+9,700
+61% +$896K 1% 16
2023
Q2
$1.46M Buy
+16,000
New +$1.31M 0.65% 38
2020
Q3
Sell
-1,477
Closed -$293K 120
2020
Q2
$293K Buy
+1,477
New +$275K 0.22% 104

Other funds holding AMED

Diametric Capital's AMED Position: Q3 2025 in Review

Diametric Capital sold out of Amedisys (AMED) in Q3 2025, closing a stake of 9,022 shares — an estimated $888K sold.

Diametric Capital first reported a position in AMED in Q2 2020 and held it in 9 quarters. The position peaked at $2.4M in Q3 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Diametric Capital reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Diametric Capital sold 9,022 Amedisys shares in Q3 2025, an estimated $888K.
  • Diametric Capital first reported a position in Amedisys in Q2 2020 and held it in 9 quarters.
  • Diametric Capital's Amedisys position peaked at $2.4M in Q3 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Diametric Capital's 13F filing for Q3 2025, filed 13 Nov 2025.